THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER

Creative Commons License

Aydogan B., Ersoz C., SAK S., Gullu S.

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.14, sa.1, ss.55-65, 2018 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4183/aeb.2018.55
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.55-65
  • Anahtar Kelimeler: Differentiated thyroid cancer, NIS, PTEN, Galectin-3, Prognosis, Lymph node metastasis, Ki-67, SODIUM-IODIDE SYMPORTER, PROGNOSTIC SCORING SYSTEM, GALECTIN GENE FAMILY, TUMOR PROGRESSION, BRAF MUTATION, PAPILLARY, EXPRESSION, CARCINOMA, PTEN, MICROCARCINOMA
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Context. There is no consensus regarding routine usage and benefits of molecular markers for prediction of prognosis and assessment of risk groups in differentiated thyroid cancer (DTC).